비교리스트

 카트 문의
시장보고서
상품코드
1631548

자궁근종 치료 기기 시장 규모, 점유율, 동향 분석 리포트 : 테크놀러지별, 치료 모드별, 지역별, 부문별 예측(2025-2030년)

Uterine Fibroids Treatment Devices Market Size, Share & Trends Analysis Report By Technology (Surgical Techniques, Laparoscopic Techniques), By Mode Of Treatment, By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

자궁근종 치료 기기 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 자궁근종 치료 기기 시장 규모는 2030년까지 121억 달러에 달할 것으로 추정되며, 2025-2030년에 9.4%의 CAGR로 성장할 전망입니다.

자궁근종 환자 증가와 자궁근종 진단 및 치료와 관련된 인식 증가가 시장을 주도하고 있습니다.

자궁근종(UF) 치료를 위한 최소침습적 및 비침습적 수술은 이러한 시술과 관련된 위험 감소로 인해 인기를 얻고 있습니다. 작은 절개는 수술 후 통증을 줄이고 빠른 회복을 촉진하므로 이러한 시술의 높은 채택률로 이어져 이 분야의 연구 및 개발의 성장을 주도하고 있습니다. 많은 주요 기업이 혁신적인 최소침습 및 비침습 수술기구를 출시하기 위해 연구개발에 투자하고 있습니다.

또한 시장 진출기업의 다양한 인식 제고 캠페인, 신제품 출시, 신기술 도입은 예측 기간 중 시장 성장을 가속할 것으로 예상됩니다. 예를 들어 Merit Medical과 같은 회사는 자궁근종에 대한 인식을 확산시키는 것뿐만 아니라 수술에 대한 안전하고 효과적인 대안을 전파하는 데 전념하고 있습니다. 그들은 또한 자궁근종과 자궁근종 색전술(UFE)의 이점을 바탕으로 인포그래픽, 브로셔, 월간 기사, 뉴스레터 등 Ask4UFE 환자 교육 프로그램을 제공합니다.

자궁 근종 치료 장비 시장 보고서 하이라이트:

  • 수술 기술 부문은 2024년 여성들의 자궁근종 발병률 증가와 효과적인 수술적 개입의 필요성 증가로 인해 34.0%의 매출 점유율로 시장을 지배할 것으로 예상됩니다.
  • 절제 기술 부문은 예측 기간 중 10.4%의 연평균 복합 성장률(CAGR)로 가장 높은 성장률을 보일 것으로 예상됩니다.
  • 침습적 치료 부문은 중증 자궁근종 치료에 대한 효과로 인해 2024년 가장 큰 매출 점유율을 차지하며 시장을 장악할 것으로 예상됩니다.
  • 북미 자궁근종 치료 기기 시장은 2024년 48.2% 매출 점유율을 차지하며 세계 시장을 장악할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 자궁근종 치료 기기 시장 변수, 동향, 범위

  • 시장 계통 전망
  • 시장 역학
    • 시장 드라이버 분석
    • 시장 성장 억제요인 분석
  • 비즈니스 환경 분석
    • 업계 분석 - Porter's Five Forces 분석
    • PESTLE 분석

제4장 자궁근종 치료 기기 시장 : 테크놀러지 비즈니스 분석

  • 테크놀러지 시장 점유율, 2024년과 2030년
  • 테크놀러지 부문 대시보드
  • 시장 규모와 예측 및 동향 분석, 테크놀러지별, 2018에서 2030년
  • 외과수술 기술
  • 복강경 기술
  • 절제 기술
  • 색전술

제5장 자궁근종 치료 기기 시장 : 치료 모드의 비즈니스 분석

  • 치료 모드 시장 점유율, 2024년과 2030년
  • 치료 모드 부문 대시보드
  • 시장 규모와 예측 및 동향 분석, 치료 모드별, 2018-2030년
  • 침습적 치료
  • 저침습치료
  • 비침습적 치료

제6장 자궁근종 치료 기기 시장 : 지역별 추정·동향 분석

  • 지역별 시장 점유율 분석, 2024년 및 2030년
  • 지역 시장 대시보드
  • 시장 규모와 예측 동향 분석, 2018-2030년 :
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 노르웨이
    • 덴마크
    • 스웨덴
    • 러시아
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
    • 콜롬비아
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제7장 경쟁 구도

  • 참가자 개요
  • 기업의 시장 현황 분석
  • 기업 분류
  • 전략 지도제작
  • 기업 개요/상장기업
    • Medtronic
    • Stryker
    • Boston Scientific Corporation
    • Insightec.
    • CooperSurgical Inc.
    • Hologic, Inc.
    • Lumenis Be Ltd
    • CONMED Corporation.
    • Gynesonics
    • Merit Medical Systems.
KSA 25.02.18

Uterine Fibroids Treatment Devices Market Growth & Trends:

The global uterine fibroids treatment devices market size is estimated to reach USD 12.1 billion by 2030, registering to grow at a CAGR of 9.4% from 2025 to 2030 according to a new report by Grand View Research, Inc. An increasing population of uterine fibroids patients and rising awareness initiatives related to fibroids diagnosis and treatment are driving the market.

Minimally invasive and non-invasive surgeries for the treatment of Uterine Fibroids (UF) are gaining popularity owing to the reduced risk associated with these procedures. Smaller incisions decrease post-operative pain and facilitate speedy recovery, thus leading to high adoption of these procedures and triggering the growth of R&D in this field. Many key players are investing in research and development for the launch of innovative minimally and non-invasive surgical instruments.

Furthermore, several awareness campaigns, new product launches, and incorporation of new technologies by market players are expected to fuel the market growth during the forecast period. For instance, companies such as Merit Medical are dedicated to spreading fibroid awareness as well as promoting a safe and effective alternative to surgery. They also provide Ask4UFE patient educational programs, such as infographics, brochures, monthly articles, and newsletters, based on uterine fibroids and the benefits of uterine fibroid embolization (UFE).

Uterine Fibroids Treatment Devices Market Report Highlights:

  • The surgical techniques segment dominated the market with a revenue share of 34.0% in 2024, attributed to the increasing prevalence of uterine fibroids among women, necessitating effective surgical interventions.
  • The ablation techniques segment is projected to grow at the highest CAGR of 10.4% over the forecast period.
  • The invasive treatment segment dominated the market with the largest revenue share in 2024, attributed to its established efficacy in treating severe uterine fibroids.
  • North America uterine fibroids treatment devices market dominated the global market, with a revenue share of 48.2% in 2024, driven by high healthcare spending and advanced medical infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Mode of Treatment
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Uterine Fibroids Treatment Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Uterine Fibroids Treatment Devices Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
  • 4.4. Surgical Techniques
    • 4.4.1. Surgical Techniques Market, 2018 - 2030 (USD Billion)
    • 4.4.2. Hysterectomy
      • 4.4.2.1. Hysterectomy Market, 2018 - 2030 (USD Billion)
    • 4.4.3. Myomectomy
      • 4.4.3.1. Myomectomy Market, 2018 - 2030 (USD Billion)
  • 4.5. Laparoscopic Techniques
    • 4.5.1. Laparoscopic Techniques Market, 2018 - 2030 (USD Billion)
    • 4.5.2. Laparoscopic Myotectomy
      • 4.5.2.1. Laparoscopic Myotectomy Market, 2018 - 2030 (USD Billion)
    • 4.5.3. Myolysis
      • 4.5.3.1. Myolysis Market, 2018 - 2030 (USD Billion)
  • 4.6. Ablation Techniques
    • 4.6.1. Ablation Techniques Market, 2018 - 2030 (USD Billion)
    • 4.6.2. Microwave Ablation
      • 4.6.2.1. Microwave Ablation Market, 2018 - 2030 (USD Billion)
    • 4.6.3. Hydrothermal Ablation
      • 4.6.3.1. Hydrothermal Ablation Market, 2018 - 2030 (USD Billion)
    • 4.6.4. Cryoablation
      • 4.6.4.1. Cryoablation, 2018 - 2030 (USD Billion)
    • 4.6.5. Ultrasound Ablation
      • 4.6.5.1. Ultrasound Ablation Market, 2018 - 2030 (USD Billion)
      • 4.6.5.2. High Intensity Focused Ultrasound (HIFU)
        • 4.6.5.2.1. High Intensity Focused Ultrasound (HIFU) Market, 2018 - 2030 (USD Billion)
      • 4.6.5.3. MRI-guided Focused Ultrasound (MRgFUS)
        • 4.6.5.3.1. MRI-guided Focused Ultrasound (MRgFUS) Market, 2018 - 2030 (USD Billion)
  • 4.7. Embolization Techniques
    • 4.7.1. Embolization Techniques Market, 2018 - 2030 (USD Billion)

Chapter 5. Uterine Fibroids Treatment Devices Market: Mode of Treatment Business Analysis

  • 5.1. Mode of Treatment Market Share, 2024 & 2030
  • 5.2. Mode of Treatment Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Mode of Treatment, 2018 to 2030 (USD Billion)
  • 5.4. Invasive Treatment
    • 5.4.1. Invasive Treatment Market, 2018 - 2030 (USD Billion)
  • 5.5. Minimally Invasive Treatment
    • 5.5.1. Minimally Invasive Treatment Market, 2018 - 2030 (USD Billion)
  • 5.6. Non-invasive Treatment
    • 5.6.1. Non-invasive Treatment Market, 2018 - 2030 (USD Billion)

Chapter 6. Uterine Fibroids Treatment Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Canada Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Europe
    • 6.5.1. Europe Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Uterine Fibroids Treatment Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.5.10. Russia
      • 6.5.10.1. Key Country Dynamics
      • 6.5.10.2. Regulatory Framework
      • 6.5.10.3. Competitive Insights
      • 6.5.10.4. Russia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Latin America
    • 6.7.1. Latin America Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Framework
      • 6.7.4.3. Competitive Insights
      • 6.7.4.4. Colombia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. MEA
    • 6.8.1. MEA Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Medtronic
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Technology Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Stryker
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Technology Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Boston Scientific Corporation
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Technology Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Insightec.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Technology Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. CooperSurgical Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Technology Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Hologic, Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Technology Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Lumenis Be Ltd
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Technology Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. CONMED Corporation.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Technology Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Gynesonics
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Technology Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Merit Medical Systems.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Technology Benchmarking
      • 7.5.10.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제